These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 34468139
1. Rapid and Sensitive SERS-Based Lateral Flow Test for SARS-CoV2-Specific IgM/IgG Antibodies. Srivastav S, Dankov A, Adanalic M, Grzeschik R, Tran V, Pagel-Wieder S, Gessler F, Spreitzer I, Scholz T, Schnierle B, Anastasiou OE, Dittmer U, Schlücker S. Anal Chem; 2021 Sep 14; 93(36):12391-12399. PubMed ID: 34468139 [Abstract] [Full Text] [Related]
4. A gold nanoparticles-based lateral flow assay utilizing baculovirus expressed recombinant nucleocapsid and receptor binding domain proteins for serodetection of IgG and IgM against SARS-CoV-2. Salem R, Elshamy AM, Kamel N, Younes S, Marie OM, Waly FR, El-Kholy AA, Elmenofy W. Biotechnol Lett; 2022 Dec 14; 44(12):1507-1517. PubMed ID: 36319880 [Abstract] [Full Text] [Related]
10. Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response. David A, Scott L, Jugwanth S, Gededzha M, Kahamba T, Zwane N, Mampeule N, Sanne I, Stevens W, Mayne ES. J Immunol Methods; 2021 Sep 14; 496():113096. PubMed ID: 34242653 [Abstract] [Full Text] [Related]
14. Comparative assessment of homemade ELISA and lateral flow assay (LFA)in the rapid, specific and sensitive detection of SARS-CoV-2 anti-nucleocapsid protein in sera of Egyptian patients. El-Shershaby A, Hussein N, Ali E, El-Hakim A, Tabll A, Shaheen M, Ali I, Elshall M, Shahein Y. J Immunoassay Immunochem; 2023 Jul 04; 44(4):338-359. PubMed ID: 37319429 [Abstract] [Full Text] [Related]
17. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies. Velay A, Gallais F, Benotmane I, Wendling MJ, Danion F, Collange O, De Sèze J, Schmidt-Mutter C, Schneider F, Bilbault P, Meziani F, Fafi-Kremer S. Diagn Microbiol Infect Dis; 2020 Dec 04; 98(4):115181. PubMed ID: 32957073 [Abstract] [Full Text] [Related]
18. Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use. Nilsson AC, Holm DK, Justesen US, Gorm-Jensen T, Andersen NS, Øvrehus A, Johansen IS, Michelsen J, Sprogøe U, Lillevang ST. Int J Infect Dis; 2021 Feb 04; 103():381-388. PubMed ID: 33310021 [Abstract] [Full Text] [Related]
19. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?]. Alessi D, Borré S, Barale A, Isabella A, Milano F, Rossi MA, Silano V, Piu N, Cena T, Faggiano F, Gruppo di Lavoro Fondazione Valsesia. Epidemiol Prev; 2020 Feb 04; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811 [Abstract] [Full Text] [Related]
20. Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies. Guo CC, Mi JQ, Nie H. Eur Rev Med Pharmacol Sci; 2020 Oct 04; 24(19):10208-10218. PubMed ID: 33090430 [Abstract] [Full Text] [Related] Page: [Next] [New Search]